SKIN RESEARCH AND TECHNOLOGY, a distinguished publication by Wiley, stands at the forefront of dermatological science, emphasizing innovative research and technological advances in skin health. With an ISSN of 0909-752X and an E-ISSN of 1600-0846, this journal serves as a vital platform for researchers and professionals to present their findings and engage in discussions surrounding skin biology, clinical practices, and therapeutic technologies. As evidenced by its respectable Q2 ranking in the dermatology category for 2023 and a Q3 status in miscellaneous medicine, the journal attracts a broad readership and contributes significantly to the field. Housed in the United Kingdom with publications spanning from 1995 to 2024, SKIN RESEARCH AND TECHNOLOGY continues to foster innovation and knowledge dissemination in skin-related research. While its Access options are not open, the impact of the journal remains prominent, appealing to academic professionals and students eager to explore emerging trends and advancements in dermatological studies.

The American Journal of Clinical Dermatology, published by Adis International Ltd, is a leading peer-reviewed journal dedicated to advancing the field of dermatology. With a notable impact factor and a prestigious Q1 rank in both Dermatology and Miscellaneous Medicine categories, this journal stands out as a valuable resource for researchers and clinicians alike, offering cutting-edge insights into clinical practice and innovative treatment strategies. Its comprehensive scope encompasses a broad range of topics within dermatology, addressing both common and rare conditions, with a focus on emerging therapies and technologies. As it converges its publication years from 2000 to 2024, the journal remains an essential platform for disseminating high-quality research to professionals striving to improve patient care and outcomes. With the ISSN 1175-0561 and E-ISSN 1179-1888, the American Journal of Clinical Dermatology facilitates greater accessibility to pivotal findings within the field, making it an indispensable resource for anyone involved in dermatological research and practice.

JAMA Dermatology, an esteemed publication by the American Medical Association, is positioned at the forefront of dermatological research and clinical practice. With an ISSN of 2168-6068 and an E-ISSN of 2168-6084, this journal underscores a commitment to disseminating high-quality and impactful research within the field. Notably ranked Q1 in both Dermatology and Miscellaneous Medicine for 2023, JAMA Dermatology ranks among the top journals in its category, holding the impressive 3rd position out of 142 in Scopus's dermatology rankings, placing it in the 98th percentile. With converged years extending from 2013 to 2024, the journal emphasizes timely and critical advancements in dermatological science. Furthermore, as a champion of open access, it encourages a broad dissemination of knowledge, making essential research accessible to a wider audience. Researchers, professionals, and students alike will find JAMA Dermatology to be an invaluable resource for the latest findings, innovative therapies, and in-depth reviews that shape the future of dermatological health.

Dermatology Research and Practice is a premier open access journal published by HINDAWI LTD, dedicated to advancing the field of dermatology since its establishment in 2009. With a respectable impact factor and a ranking of #42 out of 142 in the Scopus Medicine - Dermatology category, the journal stands in the 70th percentile, reflecting its influence and relevance in contemporary dermatological research. Based in Egypt, it provides a platform for groundbreaking studies that shape clinical practice and policy worldwide. The journal covers a wide range of topics within dermatology, including but not limited to clinical research, epidemiology, and patient care, making it an essential resource for researchers, healthcare professionals, and students seeking to enhance their understanding and contribute to the field. Emphasizing open access, Dermatology Research and Practice ensures that vital research findings are readily available to the global community, fostering collaboration and innovation in dermatology.

AKTUELLE DERMATOLOGIE is a distinguished journal in the field of Dermatology, published by GEORG THIEME VERLAG KG in Germany. With a commitment to advancing knowledge and practice in dermatological science, the journal has regularly featured research articles, reviews, and case studies since its inception in 1975 and continues to publish contributions through 2024. Despite being categorized in the lower quartile (Q4) of dermatology journals and holding a Scopus rank of #127 out of 142, it plays a pivotal role in disseminating valuable insights that support ongoing education and research in the discipline. The journal provides an essential platform for both seasoned professionals and budding researchers to share their findings, explore emerging trends, and discuss clinical practices, all while serving the needs of an evolving medical landscape. Access to its content may be restricted, but the journal remains a crucial reference for those invested in the future of dermatological research and patient care.

Actas Dermo-Sifiliograficas, published by Elsevier España, stands as a pivotal resource in the realms of dermatology, histology, and pathology and forensic medicine. With its ISSN of 0001-7310 and E-ISSN 1578-2190, this esteemed journal has transitioned to an Open Access model since 2020, facilitating broader dissemination of impactful research. Operating from its Madrid headquarters, it has been a vital platform for scholarly exchange since its inception in 1945, continuing through its converged years until 2024. The journal holds a Q3 ranking in dermatology, histology, and pathology and forensic medicine as of 2023, reflecting its relevance in the academic community where it ranks 79th in dermatology and 126th in pathology among its peers. With a commitment to advancing knowledge and practice in its fields, Actas Dermo-Sifiliograficas serves as an essential repository for researchers, professionals, and students seeking to engage with the latest findings and innovative perspectives in skin and disease research.

Journal of Drugs in Dermatology, an esteemed publication in the field of dermatology, serves as a vital resource for researchers, clinicians, and healthcare professionals dedicated to advancing knowledge and practices in skin-related therapies and treatments. Established in 2002 and published in the United States, this journal focuses on a wide range of topics pertinent to dermatological pharmacology and therapeutics, reflecting contemporary scientific advancements and innovative approaches to patient care. With a strong presence in Scopus rankings, situating it at rank #73 within the dermatology category, and achieving a commendable Q2 quartile classification in both dermatology and general medicine categories, the journal is committed to enhancing understanding of drug efficacy and safety in dermatological conditions. While the journal maintains a traditional access model, its impact factor underscores its significance in the research community, supporting the ongoing dialogue between academia and clinical practice. We invite professionals and students alike to explore the latest findings and contribute to the progressive discourse on dermatological treatments through this important publication.

The JOURNAL OF DERMATOLOGICAL TREATMENT, published by TAYLOR & FRANCIS LTD, is a premier forum dedicated to advancing the field of dermatology through the dissemination of high-quality research. Since its inception in 1989, this journal has maintained a significant impact on the dermatological community, currently ranking in the top quartile (Q1) of the Dermatology category with an impressive Scopus ranking of #14 out of 142 journals, reflecting its reputation among peers and its contribution to the clinical and academic landscape. The journal shifted to Open Access in 2023, enhancing the accessibility of groundbreaking findings to researchers, clinicians, and students worldwide. With a commitment to publishing diverse articles, from innovative treatment modalities to comprehensive reviews, the JOURNAL OF DERMATOLOGICAL TREATMENT serves as an invaluable resource for professionals seeking to stay at the forefront of dermatological science in a rapidly evolving field.

The Journal of Cutaneous Immunology and Allergy, published by FRONTIERS MEDIA SA in Switzerland, is an esteemed Open Access platform dedicated to advancing research in the intersecting fields of dermatology, immunology, and allergy. Since its inception in 2018, this journal has provided a vital resource for the dissemination of innovative research findings and critical reviews, enhancing our understanding of cutaneous conditions related to immune responses. Although currently classified in the Q4 quartile in both Dermatology and Immunology & Allergy categories as of 2023, the journal continues to strive for recognition within the scientific community, encouraging collaboration and knowledge sharing among researchers, clinicians, and experts. The journal boasts an E-ISSN of 2574-4593 and is committed to making high-quality research freely accessible to all, thus fostering greater insights into the complexities of skin-related immune disorders. Join us in this journey to explore the forefront of cutaneous research and contribute to the evolving dialogue in this dynamic field.

Dermatology Practical & Conceptual is a prominent open-access journal dedicated to advancing the field of dermatology through the dissemination of cutting-edge research and practical insights. Published by MATTIOLI 1885, this peer-reviewed journal has been committed to open access since 2015, ensuring that valuable information is readily available to researchers, healthcare professionals, and students worldwide. With a focus on innovative and practical approaches in dermatology, as well as its intersections with genetics, molecular biology, and oncology, the journal has established a strong academic presence, achieving a Q2 ranking in Dermatology and notable positions in related fields for 2023. Although its Scopus rankings indicate room for improvement in certain areas, such as genetics and molecular biology, the journal's commitment to quality and accessibility is evident in its engagement with contemporary research trends. The editors invite submissions that address practical challenges and novel methodologies, fostering a multidisciplinary dialogue that enhances dermatological practice and research. The journal operates from its base in Fidenza, Italy, and as it looks toward converged years from 2019 to 2024, it aims to further strengthen its influence and contribute significantly to the dermatological landscape.